Navigation Links
Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C
Date:8/19/2009

ithout ribavirin, include hearing impairment, hearing loss, serious skin reactions, including erythema multiforme major, and infections (bacterial, viral and fungal).

Full prescribing information is available at www.rocheusa.com.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the completed Phase 3 CAPACITY program, now in pre-registration, which evaluated pirfenidone for the treatment of patients with IPF; RECAP, an open-label extension study from CAPACITY and a research program focused on small molecules for the treatment of pulmonary disease. The hepatology portfolio includes the HCV pr
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Rochester Medical Reports Third Quarter Results
2. Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
3. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
4. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
5. Roche Diabetes Care Announces Unique Coaching Program for Diabetes Educators as Part of Long-Term Commitment to Fight the Disease
6. NJLRA Statement in Response to Roches Discontinuation of Accutane(R)
7. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
8. Purple Communications Dream Bigger Initiative Honors Rochester Physician and Deaf Community Trailblazer
9. Rochester Medical Corporation Set to Join Russell 3000 Index
10. Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
11. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... veterans receiving mental health services from the Veterans Health ... improvement among all areas studied. , The RAND Corporation ... with a substance use disorder were less satisfied than ... substance abuse problems also were less likely than others ... their decisions. , The findings, published in the journal ...
(Date:8/20/2014)... 2014 Ticket Down is a reliable ... FL at the Sun Life Stadium in early September. , ... when Brazil and Colombia meet at Sun Life Stadium in Miami ... teams in the world and will be a rematch of their ... will kick-off on Sept. 5 and will feature some of the ...
(Date:8/20/2014)... 20, 2014 BCC Research ( ... PHOTONIC SENSORS AND DETECTORS: TECHNOLOGIES AND GLOBAL MARKETS ... is expected to grow to $15.2 billion by ... (CAGR) of 15.9%. Increasing industrialization is driving ... a rapidly expanding range of industrial applications such ...
(Date:8/20/2014)... 2014 The Institute for Integrative ... proud to announce its new partnership with ... cutting-edge university offering graduate programs featuring flexible learning. ... are now eligible to receive six graduate credits ... Studies. , “I’m so thrilled to announce this ...
(Date:8/20/2014)... 20, 2014 One Call Alert expands its ... of ResCube, a fully-mobile wearable device that connects customers to ... button, 24 hours a day, 365 days a year. , ... cross country. It operates on the T-Mobile nationwide network like ... in to work. , Like with the other One Call ...
Breaking Medicine News(10 mins):Health News:Survey finds veterans generally satisfied with mental health care 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 3Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 3Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 3Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3
... boosts production of bone-eroding cells , , MONDAY, Dec. 3 (HealthDay ... diabetes patients, may contribute to bone loss, according to a ... the long term, Avandia (rosiglitazone) may speed osteoporosis, the thinning ... fatal fractures. , The findings appear in the Dec. 2 ...
... choices, even chewing gum, can help keep extra pounds at bay, ... is such a focal point of the holidays, it,s all too ... in celebration. , But a bit of planning may help you ... and dietetics at Saint Louis University. , "It,s OK to indulge ...
... Dec. 2 The United States,Conference of Mayors and ... as World AIDS Day. America,s mayors support every effort ... and growing,impact of HIV/AIDS., Since the pandemic was ... worldwide have died from AIDS and 33 million are ...
... Bush, U2,s Bono and Others Challenge 5,000 Teens via, Simulcast to 200 ... ... Cure, LAKE FOREST, Calif., Dec. 1 ... Saddleback Church, held on World AIDS Day, which capped a,four-day Global Summit on ...
... and Confidential HIV Testing and ... World AIDS Day 2007, LOS ANGELES, Dec. 1 ... Earvin "Magic" Johnson, and,Abbott are bringing the "I Stand With ... women, on HIV/AIDS,prevention and treatment. The program aims to reduce ...
... can trigger symptoms, experts warn , SATURDAY, Dec. 1 (HealthDay ... the season of sneezing, congestion and other woes for ... at the American Academy of Allergy, Asthma & Immunology (AAAAI). ... minimum, they say. , "Whether it,s feasting on holiday meals, ...
Cached Medicine News:Health News:Diabetes Drug Avandia Could Weaken Bones 2Health News:Holidays Don't Have to Leave You Heavier 2Health News:The United States Conference of Mayors Observes World AIDS Day 2Health News:First-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day: 2Health News:First-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day: 3Health News:Cookie Johnson and Abbott Bring 'I Stand With Magic: Campaign to End Black AIDS' to Los Angeles to Educate African-American Women on HIV/AIDS 2Health News:Cookie Johnson and Abbott Bring 'I Stand With Magic: Campaign to End Black AIDS' to Los Angeles to Educate African-American Women on HIV/AIDS 3Health News:Cookie Johnson and Abbott Bring 'I Stand With Magic: Campaign to End Black AIDS' to Los Angeles to Educate African-American Women on HIV/AIDS 4Health News:'Tis the Season For Allergy, Asthma 2
(Date:8/20/2014)... Reportbuyer.com has added a new market research report: ... This report analyzes the worldwide markets ... Product Segments: Implantable/Internal Cardiac Defibrillators, and External Defibrillators. The ... Canada , Japan , ... , Middle East & ...
(Date:8/20/2014)... 2014 Children aren,t the only segment ... help prevent disease. The Centers for Disease Control ... but currently, many adults are not following this ... Awareness Month, and the American Lung Association in ... with lung disease, to talk with their health ...
(Date:8/20/2014)... New York , August 20, 2014 ... a new market report titled "Monochloroacetic Acid (MCA) Market ... Applications - Global Industry Analysis, Size, Share, Growth, Trends ... market was valued at USD 817.1 million in 2013 ... 2020, growing at a CAGR of 3.6% during the ...
Breaking Medicine Technology:Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 2American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4
... Feb. 17, 2012  The Fraxion™ head frame helps ensure ... cancer targets in the brain and cranium. Elekta,s Fraxion ... integrates all proven cranial immobilization options in a single ... years of stereotaxy experience, Fraxion provides the accuracy and ...
... ("CTI") (NASDAQ and MTA: CTIC) announced today that ... opinion for conditional approval from the European Medicines ... Use ("CHMP"). Based on the CHMP,s recommendation, CTI ... should be granted by the European Commission within ...
Cached Medicine Technology:Elekta's Fraxion System Brings Proven Immobilization Options Into One Single Solution for Stereotactic Radiation Therapy of the Brain and Cranium 2European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™ 2European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™ 3European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™ 4European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™ 5
... Web Edition, gives the Physician, the Administrator ... the MD Coder Web Edition over the ... and features of the Enterprise Server but ... training, maintenance, upgrades and white glove user ...
ZapICD is a reference to the complete set of ICD codes....
... MD Coder is simply more ... is a handheld solution for ... for both individual physicians and ... v6.0 now comes in three ...
In addition to the patient data OB-on-Call contains a comprehensive Medications list displaying related drugs by brand name, generic title, and usage description notes....
Medicine Products: